Abbott Laboratories filed to offer nearly a third of its stake in Mylan NV that it got from the recent sale of a portion of its generic-drugs business to the Netherlands-based drug maker.
from WSJ.com: US Business http://ift.tt/19oeQcr
via IFTTT
from WSJ.com: US Business http://ift.tt/19oeQcr
via IFTTT
No comments:
Post a Comment